Cognitive Function 1, Social
34
0
1
26
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
1 terminated out of 34 trials
96.3%
+9.8% vs benchmark
6%
2 trials in Phase 3/4
0%
0 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (34)
System-IGF-1 Pathway and Alzheimer's Disease
Optimizing Cognition Via Exercise and Nutrition
Effect of Moringa Royal Jelly on the Nutritional Status and Cognitive Level of Adolescent Girls
Effects of an Exercise Program on Cognition and Brain in Overweight/Obese Preadolescent Children
Understanding Cerebral Blood Flow Dynamics for Alzheimer's Disease Prevention Through Exercise
The Effect of Dual Task on Postural Control in Children Diagnosed with Epilepsy
Cognitive Skills and Reading Speed
Prenatal Affective Cognitive Training to Reduce the Risk of Postpartum Depression (PACT)
Investigating Gains in Neurocognition in an Intervention Trial of Exercise
Active Gains in Brain Using Exercise During Aging
Playfulness in Online and Face-to-face Interactions, From Adulthood to Aging
The Cogni-Action Project: Physical Activity, Brain, and Cognition
Weather Sensitivity and the Effects of Walking in Nature on Stress Response of Individuals With Coronary Artery Disease
Caffeine, DNA and Cognition
The Effect of Listening Effort, Cognition and Anxiety-depression in Listening Satisfaction by Hearing Aid Users
Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects
Wellbeing, Stress Reduction and Social Cognition
PJ-011726 IntelliSpace Cognition MCI Study
The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health
The Effect of Cognitive Function Training Program for Community Elderly